Skip to main content

PURE BIOSCIENCE, INC.

For the period ended Jul 31, 2026. Filed Oct 29, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Oct 29, 2026

PUREStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PURE BIOSCIENCE, INC.DATE
/s/ Jeff KitchellOctober 29, 2026
Jeff Kitchell
President and Chief Executive Officer

Power of Attorney

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Jeff Kitchell and Mark Elliott, and each of them, as his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes, may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report is signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

NAMETITLEDATE
/s/ JEFF KITCHELLPresident, Chief Executive Officer, DirectorOctober 29, 2026
Jeff KitchellPrincipal Executive Officer
/s/ MARK ELLIOTTVice President, FinanceOctober 29, 2026
Mark ElliottPrincipal Financial and Accounting Officer
/s/ IVAN CHENChairman of the BoardOctober 29, 2026
Ivan Chen
/s/ TOM MYERSDirectorOctober 29, 2026
Tom Myers
/s/ DAVID RENDALLDirectorOctober 29, 2026
David Rendall
/s/ TOM Y. LEEDirectorOctober 29, 2026
Tom Y. Lee
/s/ ROBERT BARTLETTDirectorOctober 29, 2026
Robert Bartlett
/s/ DARIN ZEHRDirectorOctober 29, 2026
Darin Zehr

Index to Consolidated Financial Statements

Report of Independent Registered Public Accounting Firm PCAOB ID NO: 572F-2
Consolidated Balance Sheets as of July 31, 2026 and 2025F-3
Consolidated Statements of Operations for the years ended July 31, 2026 and 2025F-4
Consolidated Statements of Stockholders’ Deficiency for the years ended July 31, 2026 and 2025F-5
Consolidated Statements of Cash Flows for the years ended July 31, 2026 and 2025F-6
Notes to Consolidated Financial StatementsF-7
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.